CXCR1/2 Regulates Human Breast Cancer Stem Cell Activity Via EGFR/HER2-Dependent and -Independent Pathway.

被引：0
|
作者：
Singh, J. K. [1 ]
Farnie, G. [1 ]
Clarke, R. B. [1 ]
Bundred, N. J. [1 ]
机构：
[1] Univ Manchester, Paterson Inst Canc Res, Sch Canc & Enabling Sci, Manchester, Lancs, England
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P3-17-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-17-04
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
    Singh, Jagdeep K.
    Farnie, Gillian
    Bundred, Nigel J.
    Simoes, Bruno M.
    Shergill, Amrita
    Landberg, Goeran
    Howell, Sacha J.
    Clarke, Robert B.
    CLINICAL CANCER RESEARCH, 2013, 19 (03) : 643 - 656
  • [2] CXCR1/2 signalling regulates human breast cancer stem cell activity
    Singh, J. K.
    Farnie, G.
    Clarke, R. B.
    Bundred, N. J.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 8 - 9
  • [3] AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer
    Dingxie Liu
    Cellular Oncology, 2020, 43 : 321 - 333
  • [4] AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer
    Liu, Dingxie
    CELLULAR ONCOLOGY, 2020, 43 (02) : 321 - 333
  • [5] HER2-dependent RNA polymerase II binding in human breast tumors defines a regulon including a stem cell network
    Rahmatpanah, Farah
    Chen, Xin
    Jia, Zhenyu
    Men, Bozhao
    McClelland, Michael
    Mercola, Dan
    CANCER RESEARCH, 2014, 74 (19)
  • [6] HER2 Regulates Cancer Stem Cell Activities via the Wnt Signaling Pathway in Gastric Cancer Cells
    Jung, Da Hyun
    Bae, Yoo Jin
    Kim, Jie-Hyun
    Shin, You Keun
    Jeung, Hei-Cheul
    ONCOLOGY, 2019, 97 (05) : 311 - 318
  • [7] Interleukin-8 promotes cell migration via CXCR1 and CXCR2 in liver cancer
    Bi, Huijuan
    Zhang, Yu
    Wang, Shanshan
    Fang, Wenhao
    He, Wenjun
    Yin, Lina
    Xue, Ying
    Cheng, Zhixiang
    Yang, Minghui
    Shen, Jilu
    ONCOLOGY LETTERS, 2019, 18 (04) : 4176 - 4184
  • [8] A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
    Goldstein, Lori J.
    Perez, Raymond P.
    Yardley, Denise
    Han, Linda K.
    Reuben, James M.
    Gao, Hui
    McCanna, Susan
    Butler, Beth
    Ruffini, Pier Adelchi
    Liu, Yi
    Rosato, Roberto R.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [9] Characterization of promoter activity of the 5′ untranslated regions of CXCR1 and CXCR2 in a human myeloid cell line
    Glynn, P
    Hall, IP
    THORAX, 1999, 54 : A8 - A8
  • [10] Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
    Lori J. Goldstein
    Raymond P. Perez
    Denise Yardley
    Linda K. Han
    James M. Reuben
    Hui Gao
    Susan McCanna
    Beth Butler
    Pier Adelchi Ruffini
    Yi Liu
    Roberto R. Rosato
    Jenny C. Chang
    Breast Cancer Research, 22
12345